Artificial chimeric proteins as diagnostic, vaccine, and gene therapy carriers

Projektinformationen

CHIMERIC PROTEINS

ID Finanzhilfevereinbarung: QLK2-CT-1999-51115

Startdatum 6 Juni 2001

Enddatum 5 Juni 2005

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 180 000,00

EU-Beitrag € 180 000,00

Koordiniert durch

UNIVERSITY OF LATVIA
Latvia

Ziel

Doctoral training in prediction, construction, and evaluation of chimerical virus- like particles (VIPs) intended to creation of advanced multipurpose vaccines, modern diagnostics, and new delivery systems for gene therapy.

Wissenschaftliches Gebiet

• medical and health sciences › medical biotechnology › genetic engineering › gene therapy
• natural sciences › biological sciences › microbiology › virology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-2. - Key action Control of Infectious Diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

UNIVERSITY OF LATVIA

• EU-Beitrag: Keine Daten
• Adresse: Ratsupites Street 1 ; 1067 RIGA ; Lettland
• Gesamtkosten: Keine Daten